Preguntas más frecuentes
En esta sección encontrarás respuesta a algunas de las preguntas más frecuentes sobre el cáncer de ovario. Las preguntas están divididas por temas: patología, diagnóstico, manejo, seguimiento y asociaciones de pacientes. Si deseas conocer más información acerca del cáncer de ovario, consulta con tu médico.
Referencias
- Kossai M, Leary A, Scoazec JY, Genestie C. Ovarian Cancer: A Heterogeneous Disease. Pathobiology. 2018;85(1-2):41-9.
- Dong A, Lu Y, Lu B. Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice. J Cancer. 2016;7(11):1441-51.
- Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. Am J Physiol Cell Physiol. 2015;309(7):C444-56.
- Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019; 11:287-99.
- Lee J-Y, Kim S, Kim YT, Lim MC, Lee B, Jung K-W, et al. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy. BMC Cancer. 2018;18(1):601.
- Webb PM, Jordan SJ. Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017; 41:3-14.
- Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol. 2018;47(2):460-72.
- Tortorella L, Vizzielli G, Fusco D, Cho WC, Bernabei R, Scambia G, et al. Ovarian Cancer Management in the Oldest Old: Improving Outcomes and Tailoring Treatments. Aging Dis. 2017;8(5):677-84.
- Stewart C, Ralyea C, Lockwood S. Ovarian Cancer: An Integrated Review. Semin Oncol Nurs. 2019;35(2):151-6.
- Prat J, D'Angelo E, Espinosa I. Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. Hum Pathol. 2018; 80:11-27.
- Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9-32.
- Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2(1):16061.
- Asociación Asaco. Cáncer de Ovario. Estadios [Internet]. Disponible en: https://www.asociacionasaco.es/cancer-de-ovario/estadios/ [último acceso: junio 2021].
- Toss A, Tomasello C, Razzaboni E, Contu G, Grandi G, Cagnacci A, et al. Hereditary ovarian cancer: not only BRCA 1 and 2 genes. Biomed Res Int. 2015; 2015:341723.
- Ali AT. Towards Prevention of Ovarian Cancer. Curr Cancer Drug Targets. 2018;18(6):522-37.
- Delgado-Ortega L, González-Domínguez A, Borrás JM, Oliva-Moreno J, González-Haba E, Menjón S, et al. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study. Eur J Health Econ. 2019;20(1):135-47.
- O’Brien KM, Tworoger SS, Harris HR, Anderson GL, Weinberg CR, Trabert B, et al. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer. JAMA. 2020;323(1):49-59.
- Ovarian Cancer. Am Fam Physician [Internet]. 2016;93(11). Disponible en: https://www.aafp.org/afp/2016/0601/afp20160601p937-s1.pdf [último acceso: junio 2021].
- Bankhead CR, Collins C, Stokes-Lampard H, Rose P, Wilson S, Clements A, et al. Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG. 2008;115(8):1008-14.
- Asociación Asaco. Cáncer de Ovario. Síntomas [Internet]. Disponible en: https://www.asociacionasaco.es/cancer-de-ovario/sintomas/ [último acceso: junio 2021].
- Ebell MH, Culp MB, Radke TJ. A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer. Am J Prev Med. 2016;50(3):384-94.
- SEOM: Sociedad Española de Oncología Médica. Cáncer de ovario [Internet]. Disponible en: https://seom.org/info-sobre-el-cancer/ovario?showall=1 [último acceso: junio 2021].
- Doubeni CA, Doubeni AR, Myers AE. Diagnosis and Management of Ovarian Cancer. Am Fam Physician. 2016;93(11):937-44.
- An experiment in earlier detection of ovarian cancer. Lancet. 2007;369(9579):2051.
- Altman AD, Lambert P, Love AJ, Turner D, Lotocki R, Dean E, et al. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group. Int J Gynecol Cancer. 2017;27(8):1637-44.
- Sundar S, Neal RD, Kehoe S. Diagnosis of ovarian cancer. BMJ. 2015;351:h4443.
- Chan YM, Ng TY, Lee PW, Ngan HY, Wong LC. Symptoms, coping strategies, and timing of presentations in patients with newly diagnosed ovarian cancer. Gynecol Oncol. 2003;90(3):651-6.
- Vine MF, Calingaert B, Berchuck A, Schildkraut JM. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol. 2003;90(1):75-82.
- Lim A, Mesher D, Gentry-Maharaj A, Balogun N, Widschwendter M, Jacobs I, et al. Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records. BJOG. 2016;123(6):1012-20.
- American Cancer Society. Pruebas para el cancer de ovario [Internet]. Disponible en: https://www.cancer.org/es/cancer/cancer-de-ovario/deteccion-diagnostico-clasificacion-por-etapas/como-se-diagnostica.html [último acceso: junio 2021].
- González-Santiago S, Ramón y Cajal T, Aguirre E, Alés-Martínez JE, Andrés R, Balmaña J, et al. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol. 2020;22(2):193-200.
- National Comprehensive Cancer Network (NCCN). NCCN guidelines for patients. Ovarian Cancer- Epithelial Ovarian Cancer 2019 [Internet]. Disponible en: https://www.nccn.org/patients/guidelines/content/PDF/ovarian-spanish-patient.pdf [último acceso: junio 2021].
- SEOM: Sociedad Española de Oncología Médica. Prevención del cáncer [Internet]. Disponible en: https://seom.org/informacion-sobre-el-cancer/prevencion-cancer?start=2 [último acceso: junio 2021].
- Jara Sánchez C, Cámara Vicario JC, Aranda Aguilar E, Benavides Orgaz M, Casas Fernández de Tejerina AM, Felip Font E, Garrido López MP, Rifá Pérez J, editores. Libro Blanco de la Oncología Médica en España [Internet]. Madrid (España): Sociedad española de Oncología Médica (SEOM); 2006. Comité de Tumores; p. 355-367. Disponible en: https://seom.org/seomcms/images/stories/recursos/sociosyprofs/planif_oncologica_espana/libroblanco_23.pdf [último acceso: junio 2021].
- Falzone L, Scandurra G, Lombardo V, Gattuso G, Lavoro A, Distefano AB, et al. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer. International Journal of Oncology. 2021; 59.1:1-14.
- SEOM: Sociedad Española de Oncología Médica. Tratamiento [Internet]. Disponible en: https://seom.org/info-sobre-el-cancer/ovario?start=8 [último acceso: junio 2021]
- Coleman RL, Monk BJ, Sood AK, Herzog TJ. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10(4):211-24.
- Martín-Cameán M, Delgado-Sánchez E, Piñera A, Diestro MD, De Santiago J, Zapardiel I. The role of surgery in advanced epithelial ovarian cancer. Ecancermedicalscience. 2016;10:1-13.
- Cortez AJ, Tudrej P, Kujawa KA, Lisowska KM. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018;81(1):17-38.
- Lancia F, Marzola M, Martinello R, Borghi C, Bernardi G, Toma I, et al. Multidisciplinary management in ovarian cancer. Ann Oncol. 2016;27:iv79
- Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951
- ESMO: European Society Medical Oncology. Ovarian Cancer: A Guide for Patients [Internet]. Disponible en: https://www.esmo.org/for-patients/patient-guides/ovarian-cancer [último acceso: junio 2021].
- Redondo A, Guerra E, Manso L, Martin-Lorente C, Martinez-Garcia J, Perez-Fidalgo JA, et al. SEOM clinical guideline in ovarian cancer (2020). Clin Transl Oncol. 2021;23(5):961-8.
- AECC: Asociación Española contra el Cáncer [Internet]. Disponible en: https://www.aecc.es/es [último acceso: junio 2021].
- Simacek K, Raja P, Chiauzzi E, Eek D, Halling K. What Do Ovarian Cancer Patients Expect From Treatment?: Perspectives From an Online Patient Community. Cancer Nurs. 2017;40(5): E17-E27.
- Gupta KK, Gupta VK, Naumann RW. Ovarian cancer: screening and future directions. Int J Gynecol Cancer. 2019;29(1):195-200.
- ASACO: Asociación de Afectados por Cáncer de Ovario [Internet]. Disponible en: https://www.asociacionasaco.es/. [último acceso: junio 2021].
UA Diciembre 2022: NP-ES-AOU-WCNT-220007(v1)